Arrowhead Pharmaceuticals ARWR
NASDAQ ARWR
$64.19 -0.60 (-0.93%)
At close: Oct 2, 2026 · 4:00 PM EDT

Arrowhead Pharmaceuticals (ARWR) Price to Earnings (2019 - 2025)

Updated

Arrowhead Pharmaceuticals' Price to Earnings came in at 45.10 for fiscal Q1 2026 (quarter ended Dec 31, 2025).

Analysis

Arrowhead Pharmaceuticals (ARWR) Price to Earnings (2019 - 2025) Analysis & Trends

For FY2019 (ended Sep 30, 2019), Arrowhead Pharmaceuticals' Price to Earnings was 39.59.

  • The fiscal Q1 2026 figure represents the highest quarterly Price to Earnings since fiscal Q2 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Arrowhead Pharmaceuticals 9.06 Bn 3.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 45.10
Mar 31, 2020 307.11
Dec 31, 2019 120.41
Sep 30, 2019 39.59
Jun 30, 2019 55.44
Mar 31, 2019 181.57
API Access

Arrowhead Pharmaceuticals Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=ARWR&period=max&api_key=YOUR_API_KEY